Differences  ||| S:0 E:12 ||| NNS
and  ||| S:12 E:16 ||| CC
similarities  ||| S:16 E:29 ||| NNS
between  ||| S:29 E:37 ||| IN
ankylosing  ||| S:37 E:48 ||| JJ
spondylitis  ||| S:48 E:60 ||| NN
and  ||| S:60 E:64 ||| CC
rheumatoid  ||| S:64 E:75 ||| JJ
arthritis ||| S:75 E:84 ||| NN
:  ||| S:84 E:86 ||| :
epidemiology  ||| S:86 E:99 ||| FW
Ankylosing  ||| S:99 E:110 ||| FW
spondylitis  ||| S:110 E:122 ||| FW
( ||| S:122 E:123 ||| -LRB-
AS ||| S:123 E:125 ||| NNP
)  ||| S:125 E:127 ||| -RRB-
and  ||| S:127 E:131 ||| CC
rheumatoid  ||| S:131 E:142 ||| JJ
arthritis  ||| S:142 E:152 ||| NN
( ||| S:152 E:153 ||| -LRB-
RA ||| S:153 E:155 ||| NNP
)  ||| S:155 E:157 ||| -RRB-
are  ||| S:157 E:161 ||| VBP
among  ||| S:161 E:167 ||| IN
the  ||| S:167 E:171 ||| DT
most  ||| S:171 E:176 ||| RBS
common  ||| S:176 E:183 ||| JJ
rheumatic  ||| S:183 E:193 ||| JJ
diseases ||| S:193 E:201 ||| NNS
.  ||| S:201 E:203 ||| .
The  ||| S:203 E:207 ||| DT
epidemiology  ||| S:207 E:220 ||| NN
of  ||| S:220 E:223 ||| IN
these  ||| S:223 E:229 ||| DT
diseases  ||| S:229 E:238 ||| NNS
highlights  ||| S:238 E:249 ||| VBP
both  ||| S:249 E:254 ||| DT
similarities  ||| S:254 E:267 ||| NNS
and  ||| S:267 E:271 ||| CC
differences ||| S:271 E:282 ||| NNS
.  ||| S:282 E:284 ||| .
Prevalence  ||| S:284 E:295 ||| JJ
rates  ||| S:295 E:301 ||| NNS
of  ||| S:301 E:304 ||| IN
approximately  ||| S:304 E:318 ||| RB
0.2-1 ||| S:318 E:323 ||| CD
%  ||| S:323 E:325 ||| NN
have  ||| S:325 E:330 ||| VBP
been  ||| S:330 E:335 ||| VBN
reported  ||| S:335 E:344 ||| VBN
for  ||| S:344 E:348 ||| IN
the  ||| S:348 E:352 ||| DT
diseases ||| S:352 E:360 ||| NNS
,  ||| S:360 E:362 ||| ,
but  ||| S:362 E:366 ||| CC
the  ||| S:366 E:370 ||| DT
rate  ||| S:370 E:375 ||| NN
for  ||| S:375 E:379 ||| IN
AS  ||| S:379 E:382 ||| NNP
is  ||| S:382 E:385 ||| VBZ
increasing  ||| S:385 E:396 ||| VBG
while  ||| S:396 E:402 ||| IN
RA  ||| S:402 E:405 ||| NNP
is  ||| S:405 E:408 ||| VBZ
declining ||| S:408 E:417 ||| VBG
.  ||| S:417 E:419 ||| .
Geographical  ||| S:419 E:432 ||| JJ
variations  ||| S:432 E:443 ||| NNS
exist  ||| S:443 E:449 ||| VBP
in  ||| S:449 E:452 ||| IN
the  ||| S:452 E:456 ||| DT
incidence  ||| S:456 E:466 ||| NN
and  ||| S:466 E:470 ||| CC
prevalence  ||| S:470 E:481 ||| NN
of  ||| S:481 E:484 ||| IN
the  ||| S:484 E:488 ||| DT
diseases ||| S:488 E:496 ||| NNS
,  ||| S:496 E:498 ||| ,
although  ||| S:498 E:507 ||| IN
the  ||| S:507 E:511 ||| DT
majority  ||| S:511 E:520 ||| NN
of  ||| S:520 E:523 ||| IN
studies  ||| S:523 E:531 ||| NNS
have  ||| S:531 E:536 ||| VBP
been  ||| S:536 E:541 ||| VBN
conducted  ||| S:541 E:551 ||| VBN
in  ||| S:551 E:554 ||| IN
northern  ||| S:554 E:563 ||| JJ
Europe  ||| S:563 E:570 ||| NNP
and  ||| S:570 E:574 ||| CC
North  ||| S:574 E:580 ||| NNP
America ||| S:580 E:587 ||| NNP
.  ||| S:587 E:589 ||| .
AS  ||| S:589 E:592 ||| RB
is  ||| S:592 E:595 ||| VBZ
a  ||| S:595 E:597 ||| DT
predominantly  ||| S:597 E:611 ||| RB
a  ||| S:611 E:613 ||| DT
male  ||| S:613 E:618 ||| JJ
disorder ||| S:618 E:626 ||| NN
,  ||| S:626 E:628 ||| ,
whereas  ||| S:628 E:636 ||| IN
more  ||| S:636 E:641 ||| JJR
females  ||| S:641 E:649 ||| NNS
are  ||| S:649 E:653 ||| VBP
affected  ||| S:653 E:662 ||| VBN
by  ||| S:662 E:665 ||| IN
RA ||| S:665 E:667 ||| NNP
.  ||| S:667 E:669 ||| .
Both  ||| S:669 E:674 ||| DT
diseases  ||| S:674 E:683 ||| JJ
result  ||| S:683 E:690 ||| NN
in  ||| S:690 E:693 ||| IN
increased  ||| S:693 E:703 ||| JJ
disability ||| S:703 E:713 ||| NN
,  ||| S:713 E:715 ||| ,
reduced  ||| S:715 E:723 ||| VBN
work  ||| S:723 E:728 ||| NN
productivity ||| S:728 E:740 ||| NN
,  ||| S:740 E:742 ||| ,
and  ||| S:742 E:746 ||| CC
increased  ||| S:746 E:756 ||| JJ
mortality  ||| S:756 E:766 ||| NN
rates ||| S:766 E:771 ||| NNS
.  ||| S:771 E:773 ||| .
These  ||| S:773 E:779 ||| DT
similarities  ||| S:779 E:792 ||| NNS
and  ||| S:792 E:796 ||| CC
differences  ||| S:796 E:808 ||| NNS
may  ||| S:808 E:812 ||| MD
give  ||| S:812 E:817 ||| VB
us  ||| S:817 E:820 ||| PRP
important  ||| S:820 E:830 ||| JJ
clues  ||| S:830 E:836 ||| NNS
as  ||| S:836 E:839 ||| RB
to  ||| S:839 E:842 ||| TO
the  ||| S:842 E:846 ||| DT
aetiology  ||| S:846 E:856 ||| NN
of  ||| S:856 E:859 ||| IN
both  ||| S:859 E:864 ||| DT
diseases ||| S:864 E:872 ||| NNS
.  ||| S:872 E:874 ||| .
